Open Versus Robotic Retromuscular Ventral Hernia Repair
- Conditions
- Ventral Hernia
- Interventions
- Procedure: robotic ventral hernia repairProcedure: open ventral hernia repair
- Registration Number
- NCT03007758
- Lead Sponsor
- Prisma Health-Upstate
- Brief Summary
The purpose of this study is to determine how the robotic retromuscular hernia repair compares to the open retromuscular hernia repair for large hernia defects in patients at higher risk of wound complications.
- Detailed Description
All patients presenting to the Greenville Health System Hernia Center who meet the inclusion criteria will be considered for enrollment. Patients who qualify and agree to participate will be randomized 1:1 to robotic retromuscular ventral hernia repair or open retromuscular ventral hernia repair. Data to be collected includes the following: demographic information, medical characteristics, medications, medical and surgical history, operative details, hospital stay data, and patient-reported outcomes via a quality of life questionnaire. Post-operative follow-up will occur at 2 weeks, 6 weeks, 6 months, 1 year and 2 years.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 102
- Ventral or incisional hernia measuring ≥ 7 cm and ≤ 15 cm.
- At least one of the following risk factors: Body Mass Index > 30, Chronic Obstructive Pulmonary Disease, Diabetes Mellitus, current smoker (within 1 month)
- Current abdominal wall infection
- Presence of ileostomy, colostomy, or ileal conduit
- Center for Disease Control wound class 3 or 4
- Hernia defect < 7 cm or >15 cm
- Pregnant women
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description robotic ventral hernia repair (VHR) robotic ventral hernia repair Robotic VHR open ventral hernia repair (VHR) open ventral hernia repair Open VHR
- Primary Outcome Measures
Name Time Method Composite outcome of diagnosis of surgical site occurrence or infection, hospital readmission, or hernia recurrence Through study completion, an average of 2 years A composite outcome of events which are clinically significant including but not limited to seroma requiring procedural intervention, skin dehiscence, cellulitis, hematoma, skin necrosis, and surgical site infections which may require interventions such as wound care or antibiotic therapy.
- Secondary Outcome Measures
Name Time Method All surgical site infections Post-operatively: 2 weeks, 6 weeks, 6 months, 1 year, 2 years Length of stay at hospital measured in days Time from procedure until discharge, an expected range of 2 to10 days Quality of Life via questionnaire Baseline and Post-operatively: 2 weeks, 6 weeks, 6 months, 1 year, 2 years Surgical site occurrences requiring procedural intervention Post-operatively: 2 weeks, 6 weeks, 6 months, 1 year, 2 years All surgical site occurrences Post-operatively: 2 weeks, 6 weeks, 6 months, 1 year, 2 years Surgical site infections requiring procedural intervention Post-operatively: 2 weeks, 6 weeks, 6 months, 1 year, 2 years Operative time (procedure start to procedure finish measured in minutes) Day of surgery Cost for hospital charges from billing office Through study completion, an average of 2 years